| 英文别名 |
Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-;GDC-0941;2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine;2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine;4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine;GDC 0941;GDC-0941 (RG7321,Pictilisib);GDC-0941bismesylate;Pictilisib;Pictilisib (GDC-0941);2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine;Pictrelisib;GDC0941;ICY00EMP8P;RG7321;4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmet;2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine (ACI);4-[2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)piperazin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;GDC 941;GNE 0941;CDC-0941;CDC-0941;Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-;Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-;BCP01714;BCP01714;AKOS015966503;AKOS015966503;HMS3265I05;HMS3265I05;HMS3744A19;HMS3744A19;HMS3244H14;HMS3244H14;SDCCGSBI-0654334.P001;SDCCGSBI-0654334.P001;PICTILISIB [INN];HMS2043A16;PICTILISIB [INN];AS-19377;HMS2043A16;NS00071518;AS-19377;HMS3244H06;NS00071518;LHNIIDJUOCFXAP-UHFFFAOYSA-N;HMS3244H06;Pictilisib (USAN/INN);LHNIIDJUOCFXAP-UHFFFAOYSA-N;SB19941;Pictilisib (USAN/INN);NCGC00187482-01;SCHEMBL190812;SB19941;CHEMBL521851;NCGC00187482-01;EX-A1536;SCHEMBL190812;Q27088388;CHEMBL521851;SMR004701219;EX-A1536;957054-50-1;Q27088388;HMS3265I06;SMR004701219;PICTILISIB [USAN];957054-50-1;Pictilisib [USAN:INN];HMS3265I06;PICTILISIB [MI];PICTILISIB [USAN];RG-7321;Pictilisib [USAN:INN];NSC755385;PICTILISIB [MI];2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine;RG-7321;NCGC00187482-10;NSC755385;AC-32623;2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine;DTXSID40241930;NCGC00187482-10;PICTILISIB;CCG-264801;AC-32623;s1065;DTXSID40241930;PICTILISIB;4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;CCG-264801;BRD-K52911425-001-09-8;s1065;HMS3244H10;957054-30-7 (free base);4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;J-513238;BRD-K52911425-001-09-8;GDC0941(Pictilisib);HMS3244H10;D10189;957054-30-7 (free base);4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine;J-513238;HY-50094;GDC0941(Pict... |